Clinical Trial: Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Atopic Dermatitis
Study Type: INTERVENTIONAL
Official Title: A Phase 1, Randomized, Blinded, Placebo-controlled, Dose Escalation and Expansion Study to Investigate the Safety, Tolerability, and Preliminary Efficacy of ITK Inhibitor Soquelitinib in Participants
Brief Summary:
Safety, tolerability, and preliminary efficacy of soquelitinib in participants with moderate to severe AD
Read more